Sclerosing epithelioid fibrosarcoma
Sclerosing Epithelioid Fibrosarcoma
Sclerosing epithelioid fibrosarcoma (SEF) is a rare type of soft tissue sarcoma that is characterized by its unique histological appearance and aggressive clinical behavior. It is considered a variant of fibrosarcoma, distinguished by its sclerosing and epithelioid features.
Clinical Presentation[edit | edit source]
Patients with sclerosing epithelioid fibrosarcoma typically present with a slow-growing mass. The tumor can occur in various locations, including the extremities, trunk, and head and neck region. It is most commonly diagnosed in adults, but cases have been reported across a wide age range.
Histopathology[edit | edit source]
Histologically, SEF is characterized by nests and cords of small, round to oval epithelioid cells embedded in a densely sclerotic stroma. The tumor cells often exhibit mild nuclear atypia and scant cytoplasm. Mitotic activity is generally low, but the presence of necrosis and increased mitotic figures can be observed in more aggressive cases.
Immunohistochemistry[edit | edit source]
Immunohistochemical staining is crucial for the diagnosis of SEF. The tumor cells typically express vimentin and may show focal positivity for epithelial markers such as cytokeratin and epithelial membrane antigen (EMA). Other markers, such as CD34 and S-100, are usually negative, helping to differentiate SEF from other soft tissue tumors.
Genetic Features[edit | edit source]
Molecular studies have identified recurrent genetic alterations in SEF, including EWSR1-CREB3L1 and EWSR1-CREB3L2 gene fusions. These genetic markers can aid in the diagnosis and differentiation from other sarcomas.
Prognosis and Treatment[edit | edit source]
The prognosis for patients with sclerosing epithelioid fibrosarcoma is generally poor due to its high potential for local recurrence and distant metastasis, particularly to the lungs. Treatment typically involves wide surgical excision with negative margins. The role of radiation therapy and chemotherapy is not well established but may be considered in cases of unresectable or metastatic disease.
Differential Diagnosis[edit | edit source]
The differential diagnosis for SEF includes other soft tissue tumors such as:
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
